Low Voltage Electrical Stimulation for Depression in Parkinson's Patients
The Effect of MRI-Guided Transcranial Direct Current Stimulation on Cognitive and Affective Symptoms in Persons With Parkinson's Disease and Controls
University of South Alabama
40 participants
Aug 1, 2024
INTERVENTIONAL
Conditions
Summary
The goal of this clinical trial is to determine the relative efficacy of fMRI model guided Transcranial Direct Current Stimulation (mgTDCS) in improving the depressive symptoms of patients with Parkinson's Disease (PD). The main questions it aims to answer are: 1) Can the use of mgTDCS significantly improve the self-reported level of depression and apathy in patients with PD from pre-intervention to post-intervention compared to a sham control? 2) Can the use of mgTDCS significantly normalize the cortical eeg alpha asymmetry so commonly seen in depressed patients compared to sham mgTDCS? 3) Can the use of mgTDCS significantly improve scores on neuropsychological tests of working memory?
Eligibility
Inclusion Criteria6
- to 65 years in age.
- Parkinson's Group must have a physician dx of Parkinson's Disease
- Must meet exhibit elevated levels of depression on the Beck Depression Inventory (scores of 20 or above).
- Must be willing and able to travel of the Psychology Department for EEG and tDCS sessions.
- Participants who have undergone surgery for Deep Brain Stimulation implantation may be enrolled if advised to and monitored by their physician.
- Read and understand spoken English.
Exclusion Criteria3
- No history of or being treated for epilepsy or other seizure disorders.
- No history of penetrating head wounds or TBI greater than mild TBI.
- No history of atypical Parkinson's
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Transcranial Electrical Stimulator
Transcranial Electrical Stimulator set to 0 amps
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06467695